Austrianova is one company that does deals
that comprises high tech, life sciences and biotech. It is combined with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based firm that focuses in the enclosure of living cells or bacteria in tiny capsules for shield which is also regarded as cell encapsulation technology, isolation, storage and transportation. We were first established in the year 2007 and was advanced in Singapore's greatest research biotech hub, Biopolis that has worldwide vision in offering encapsulation services like micro encapsulation.
There is a speedy increasing area of passion in healthy repair and more detailed, in the matter of neutraceuticals which is the learning and use of probiotic bacteria. So, probiotics encapsulation was developed. The cell-in-a-box technology was created by Austranova with the target to defend, isolate, keep and transport living cells. This great creation can be used for several purposes and can be applied to probiotics, cosmetics and agriculture environmental protection and monitoring as well as developing the root of a influential exploration device.
In healthcare, this skill assists controloperate secure embedding of cells or stem cells such as cell therapy, sticking them keep away from the immune system and allowing long stage production of therapeutic molecules in patients. In biotechnology, the cell-in-a-box skill guards cells in bioreactors and fermentors and at the same time, it simplifies refining of bioproducts created from the cells and it lessen production charge too.
A wide scale cGMP facility for the construction of biomedical grade encapsulated cell items was beforehand positively constructed and right now, Austrianova is in the development of building this experience in the whole of SE Asia. This means the use of cell-in-a-box was quite a achievement for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to enable lower amounts of chemotherapy to be used more productively without the usual debilitating side results. The encapsulated cell are placed, using supraselective catheterisation, into blood vessels that goes to the tumor where they locally convert a chemotherapeutic product to its tumor toxic product.
Visit our site for more information: Cell Encapsulation, Cell Therapy, Pancreatic Cancer.
